Brazil Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... and pharmaceutical industry to reduce thefinancial burden of diseases, and the country's private healthcare sectors provide opportunities forforeign companies. However, the increasing drug rebate level has significantly undermined the profitsrecorded by generic drugmakers. The more ... \| more...	$1,175.00
Zambia Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... by both NGOs and international investors as a sign that Zambia istaking its commitment to healthcare seriously. The country suffers from a burden of both communicableand non-communicable diseases, with a high incidence of HIV and ... \| more...	$1,175.00
Portugal Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... Portugal has already made considerable savings in the healthcaresectors, with changes such as the introduction of e-prescriptions and prescribing by active ingredients,changes to reference pricing, reductions in pharmacy margins and price cuts just some of ... \| more...	$1,175.00
Lithuania Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... with the market expected to increase by a local currency margin of 2.5%year-on-year (y-o-y) to reach LTL1.68bn (US$618mn) in 2012 at consumer prices. However, in US dollarterms, the market's value will shrink by 6.3%, indicating ... \| more...	$1,175.00
Romania Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... are a small improvement, though definitely not what producerswould have wanted ideally. With part of the objective of the claw-back tax to improve the timeliness ofpayments for reimbursed medicines, which has been a major difficulty ... \| more...	$1,175.00
Qatar Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... is anticipated the drug manufacturers will (in our view eventually) help curbreliance on imports and lower prices of retail medicines in the country as a result of increased localcompetition, according to Dr Aisha al-Ansari of ... \| more...	$1,175.00
Central America Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... opportunities forgeneric drugmakers from neighbouring Latin American countries and India. We highlight that Costa Ricaand Panama can be the premier countries in the region for foreign drugmakers to expand their presence. Headline Expenditure Projections Pharmaceuticals: ... \| more...	$1,175.00
Serbia Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... consumption is also expected to rise. However, financial inefficiencies within the healthinsurance system mean that the National Health Insurance Institution (RZZO) is unable to always meet itsobligations on time, leaving patients to pay for formerly ... \| more...	$1,175.00
Hungary Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... margins and introduced insecurityto an already difficult economic environment, and we continue to expect a contraction in the size of theHungarian pharmaceutical market in 2012 and 2013. Consequently, Hungarian drugmakers will have tobecome even more ... \| more...	$1,175.00
Slovakia Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... this is realised. We do not expect either of the two private insurers - Dôvera or DutchownedUnion - will surrender their businesses without a fight, with Union in particular well-placedto oppose the move, potentially invoking ... \| more...	$1,175.00
Morocco Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... the evidence ofbribery and corruption, and the shortage of doctors in the sector. BMI believes the commitment toimprove governance and implement controls in the sector will be fulfilled in the medium-to-long term. Assuch, we maintain ... \| more...	$1,175.00
Jordan Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... generic medicines, in tandem withprice-reduction strategies. Nevertheless, the expansion of government provision and the higher uptake ofgeneric medicines will conspire to keep longer term growth steady, boosted by upward volume changes,with the patented drug market ... \| more...	$1,175.00
Medical & Diagnostic Laboratories 1/14/2013 \| published by: First Research, Inc. ... Alliance HealthCare Services, LabCorp, Quest Diagnostics, and RadNet. The commercial medical and diagnostic laboratory industry in the US consists of about 8,000 companies with combined annual revenue of about $45 billion. Medical labs account for ... \| more... Search inside this report	$129.00
Singapore Healthcare Industry 2H12 1/14/2013 \| published by: Emerging Markets Direct Reports ... centric initiative, and national electronic health records, plus the profile, comparative matrix and SWOT of the industry leading players: Parkway Holdings Ltd (Parkway), Thomson Medical Centre (TMC), Health Management International Ltd (HMI), and China Healthcare ... \| more... Search inside this report	$480.00
Indonesia Pharmaceuticals & Healthcare Industry 2H12 1/14/2013 \| published by: Emerging Markets Direct Reports ... support and pharmaceutical trade. It also covers the market trends and outlook, regulatory changes, counterfeit drugs, industry SWOT analysis and market outlook, plus profile, comparative matrix and SWOT analysis of the leading players: PT Kalbe ... \| more... Search inside this report	$450.00
AAH - Al Ahli Hospital Expansion - Doha - Construction Project Profile 1/10/2013 \| published by: World Market Intelligence ... funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The AAH - Al Ahli Hospital Expansion - Doha - Construction Project Profile is part of World Market ... \| more... Search inside this report	$75.00
Switzerland Pharmaceuticals and Healthcare Report Q1 2013 1/9/2013 \| published by: Business Monitor International ... believes the government needs to do more to alter patients' attitudestowards these drugs as this is the main growth deterrent. Headline Expenditure Projections Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% declinein ... \| more...	$1,175.00
Rehabilitation Therapy Services 1/7/2013 \| published by: First Research, Inc. ... US companies include Select Medical, Physiotherapy Associates, RehabCare Group, and US Physical Therapy. The rehabilitation therapy industry in the US consists of about 30,000 establishments (single-location companies and units of multi-location companies) with combined annual ... \| more... Search inside this report	$129.00
DiaPat GmbH - Product Pipeline Analysis. 1/3/2013 \| published by: GlobalData ... in the reliable detection of diseases at early stages and evaluation of therapy, enabling personalized medicine. The company's DiaPat technology based on the innovative coupling of capillary electrophoresis and mass spectrometry identifies up to 6,000 ... \| more... Search inside this report	$750.00
Poland Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... has shifted towards the Polishconsumer, as the harsher reimbursement regime has caused private contributions to prescriptionpayments rise. We forecast a return to growth in 2013, driven by private consumption as the Polishgovernment entrenches cuts to ... \| more...	$1,175.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... non-oil economies. Political risk remains elevated as many disputesbetween them are still unresolved. These macroeconomic uncertainties will mean lack of focus on publichealthcare provision, which further complicates the problem that the general population are unable ... \| more...	$1,175.00
Ukraine Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... represent a very large business risk for internationaldrugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'smore promising pharmaceutical markets given its favourable demographics and disease profile, itschronic lack of ... \| more...	$1,175.00
Gabon Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... and the vast majority of expenditure will be on low-marginessential medicines. Due to tepid economic growth, our outlook for Gabon's pharmaceutical market isbelow that expected to be posted by many of its sub-Saharan Africa neighbours. ... \| more...	$1,175.00
Medical Staff Peer Review 1/1/2013 \| published by: Apollo Managed Care, Inc. Policies & procedures needed by every medical group, hospital and health plan + peer:staff, peer:peer evaluation tools, references. Updated annually. \| more...	$129.00
Astma 1/1/2013 \| published by: Apollo Managed Care, Inc. Clinical evaluation and management guideline. Authoritative references. Resources include patient/parent instruction sheets and education aids, national guideline summaries and web links. Updated annually. \| more...	$119.00

< prev 1 2 3 4 5 6 7 8 9 10 next >

Research assistance

Matching geography

Start new browse

Join Alert Me now!

Healthcare: market research reports

Healthcare market research reports and industry analysis